Implantable Sensor Market
According to our latest research study on “Dry Eye Products Market Forecast to 2028 – COVID-19 Impact Analysis – by Product and Type” the market is projected to reach US$ 9,681.73 million by 2028 from US$ 6,837.26 million in 2021; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028. The report highlights trends prevailing in the market and the factors governing the market growth.
Dry eye is a chronic syndrome and is a progressive depending upon the cause and severity. It is a condition when a person does not have tears to lubricate his or her eyes. Tears are an essential part of maintaining good health of the eye and assist in providing good vision. The syndrome is commonly seen among older people and is becoming common among people spending a long time in front of the computer. The factors that can cause dry eye include age, medications, environmental conditions, long term use of contact lenses. The conditions cannot be cured completely; however, it can be managed by using medical products.
Allergan PLC (Abbvie), and Alcon (Novartis) – Notable Market Players in Dry Eye Products Market
Get Free Sample PDF Download – https://bit.ly/3Txjrzr
Dry eye is a chronic syndrome and is a progressive depending upon the cause and severity. It is a condition when a person does not have tears to lubricate his or her eyes. Tears are an essential part of maintaining good health of the eye and assist in providing good vision. The syndrome is commonly seen among older people and is becoming common among people spending a long time in front of the computer. The factors that can cause dry eye include age, medications, environmental conditions, long term use of contact lenses.
Below is the list of the growth strategies done by the players operating in the dry eye products market:
| Year | News |
| URSAPHARM Arzneimittel GmbH | URSAPHARM Arzneimittel GmbH has formed a partnership with Scope Eyecare. With the launch of the OPTASE HYLO range of dry eye products in the United States beginning in June 2021, the new partnership expands Scope’s Dry Eye Portfolio. |
| Apr-21 | OASIS Medical Inc launched its new patented cyber platform MY OASIS at SECO International 2021 in April 2021 |
| May-20 | AbbVie Inc. acquired Allergan plc as a part of company’s inorganic business strategy. The acquisition has provided the company access to and expand its business portfolio in the eye care associated markets. |
| Sep-21 | Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial of NOV03 (perfluorohexyloctane) in Dry Eye Disease with Meibomian Gland Dysfunction. |
| Jul-21 | TheraTears was acquired by Prestige Consumer Healthcare Inc. The acquisition of TheraTears added to Prestige’s leading eye care portfolio and provide the company with new long-term growth prospects. |
About The Insight Partners
The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in industries such as healthcare, media, and telecommunication.
Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.
Our research content is majorly focused toward market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, product and service, radioisotope types, application and end user, which helps our clients to gain a deeper analytical understanding of various research topics.
Contact Us
If you have any queries about this report or if you would like further information, please contact us:
North America: +1 646 491 9876
Asia Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com
